Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Lupin launches Clobetasol Propionate ointment in US

      Lupin launches Clobetasol Propionate ointment in US

      Medical Dialogues Bureau10 Oct 2018 9:40 AM IST
      New Delhi: Drug firm Lupin has launched generic Clobetasol Propionate ointment used for the treatment of inflammation and itching caused by a number...
      FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

      FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

      Medical Dialogues Bureau10 Oct 2018 9:20 AM IST
      The safety of Gardasil 9 was evaluated in about a total of 13,000 males and females. The most commonly reported adverse reactions were injection site...
      Strand Life Sciences to buy Indian Diagnostic Business of Quest Diagnostics

      Strand Life Sciences to buy Indian Diagnostic Business of Quest Diagnostics

      Medical Dialogues Bureau9 Oct 2018 5:06 PM IST
      New Delhi: Quest Diagnostics leading provider of diagnostic information services, has recently announced an agreement to sell its India medical...
      CDSCO seizes illegal cosmetics, serum worth Rs 4 crore

      CDSCO seizes illegal cosmetics, serum worth Rs 4 crore

      Medical Dialogues Bureau9 Oct 2018 11:09 AM IST
      New generation products like stem cell-based cosmetics, serums, skin whitening creams, glutathione injections, hyaluronic acid filler injections,...
      Chinese drugmaker Huahai tumbles after FDA shutout

      Chinese drugmaker Huahai tumbles after FDA shutout

      Medical Dialogues Bureau9 Oct 2018 10:12 AM IST
      European authorities said late last month they had found that Huahai did not comply with good manufacturing practices and that the company's factory...
      Stryker names Meenakshi Nevatia as New MD for  India

      Stryker names Meenakshi Nevatia as New MD for India

      Medical Dialogues Bureau9 Oct 2018 10:00 AM IST
      Prior to joining Stryker, Nevatia had a 15-year stint with Novartis. In her last assignment as the country president and pharma division head for...
      Bausch Health gets tentative FDA approval for BRYHALI Lotion

      Bausch Health gets tentative FDA approval for BRYHALI Lotion

      Medical Dialogues Bureau9 Oct 2018 9:20 AM IST
      Bryhali is a steroid treatment for the chronic condition that causes dry, red skin lesions covered with silvery scales.New Delhi: Bausch Health Cos...
      Affimed puts on hold cancer drug trial after patient death

      Affimed puts on hold cancer drug trial after patient death

      Medical Dialogues Bureau9 Oct 2018 9:00 AM IST
      New Delhi: Drug Developer Affimed N.V. has put on hold the testing of its experimental cancer drug following the death of a patient and two...
      Fujifilm India forays into endoscopy segment

      Fujifilm India forays into endoscopy segment

      Medical Dialogues Bureau8 Oct 2018 4:20 PM IST
      Presently, medical endoscopy in India is around Rs 300 crore market, in which players such as Olympus, Pentax and some domestic players operate.New...
      CDSCO launches Video Conferencing facility for promoting Pharmaceuticals Startups

      CDSCO launches Video Conferencing facility for promoting Pharmaceuticals Startups

      Medical Dialogues Bureau8 Oct 2018 2:02 PM IST
      All the stakeholders are informed to utilise this Video Conference facility by taking appointment along with details of the proposal in prescribed...
      Trivitron Healthcare eyes Rs 750 crore revenue in Financial Year 2019

      Trivitron Healthcare eyes Rs 750 crore revenue in Financial Year 2019

      Medical Dialogues Bureau8 Oct 2018 10:25 AM IST
      New Delhi: Domestic medical devices maker Trivitron Healthcare is looking to clock revenue of around Rs 750 crore in the current fiscal year, as it...
      Bank fraud: ED attaches Rs 5.4 crore assets in Sterling biotech case

      Bank fraud: ED attaches Rs 5.4 crore assets in Sterling biotech case

      Medical Dialogues Bureau8 Oct 2018 10:00 AM IST
      NEW DELHI: The Enforcement Directorate has attached assets worth Rs 5.4 crore in connection with its probe in an alleged Rs 5,700-crore bank loan...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok